WELL Health Technologies (TSE:WELL) Price Target Cut to C$7.00 by Analysts at Ventum Financial

Posted by Patrick Bannon on Nov 2nd, 2024

WELL Health Technologies (TSE:WELL – Free Report) had its target price lowered by Ventum Financial from C$8.00 to C$7.00 in a report published on Tuesday, BayStreet.CA reports. The firm currently has a buy rating on the stock.

Separately, CIBC boosted their target price on shares of WELL Health Technologies from C$4.75 to C$5.00 in a research report on Friday, August 16th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of C$6.97.

View Our Latest Stock Analysis on WELL Health Technologies

WELL Health Technologies Trading Down 0.9 %

Shares of WELL opened at C$4.39 on Tuesday. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02. WELL Health Technologies has a 12 month low of C$3.41 and a 12 month high of C$5.05. The stock has a market cap of C$1.09 billion, a PE ratio of 7.70, a P/E/G ratio of -1.93 and a beta of 1.20. The stock’s 50-day moving average is C$4.43 and its two-hundred day moving average is C$4.29.

WELL Health Technologies Company Profile

(Get Free Report)

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.